Henry Botto
- Urology top 0.1%
- Urinary Bladder and Prostate Research 26
- Urological Disorders and Treatments 18
- Rheumatology top 1%
- Molecular Medicine top 2%
- Epidemiology top 2%
- Urinary Tract Infections Management 21
-
- Prostate Cancer Diagnosis and Treatment 17
- Prostate Cancer Treatment and Research 15
-
- Bladder and Urothelial Cancer Treatments 35
- Urinary and Genital Oncology Studies 22
-
- Hormonal and reproductive studies 17
Henry Botto
113 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 134
- Urology 1.6k
- Rheumatology 901
- Molecular Medicine 246
- Epidemiology 1.5k
- Pulmonary and Respiratory Medicine 1.0k
Countries citing papers authored by Henry Botto
This map shows the geographic impact of Henry Botto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Botto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Botto more than expected).
Fields of papers citing papers by Henry Botto
This network shows the impact of papers produced by Henry Botto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Botto. The network helps show where Henry Botto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Henry Botto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2020 | 5 | |
| 3 | 2015 | 4 | |
| 4 | 2015 | 29 | |
| 5 | 2012 | 32 | |
| 6 | 2011 | 123 | |
| 7 | 2010 | 5 | |
| 8 | 2009 | 0 | |
| 9 | 2009 | 5 | |
| 10 | 2009 | 302 | |
| 11 | 2008 | 80 | |
| 12 | 2008 | 66 | |
| 13 | 2007 | 13 | |
| 14 | 2006 | 5 | |
| 15 | 2003 | 138 | |
| 16 | 2002 | 29 | |
| 17 | EAU Guidelines for the Management of Urinary and Male Genital Tract Infectionstextsuperscript1 | 2001 | 8 |
| 18 | 2001 | 367 | |
| 19 | 1996 | 109 | |
| 20 | 1994 | 4 |
About Henry Botto
Henry Botto is a scholar working on Urology, Rheumatology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery, having authored 118 papers that have together received 4.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (35 papers), Urinary Bladder and Prostate Research (26 papers), Urinary and Genital Oncology Studies (22 papers), Urinary Tract Infections Management (21 papers), Urological Disorders and Treatments (18 papers), Hormonal and reproductive studies (17 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Prostate Cancer Treatment and Research (15 papers). The work is most often cited by research in Urology (1.6k citations), Rheumatology (901 citations), Molecular Medicine (246 citations), Epidemiology (1.5k citations) and Pulmonary and Respiratory Medicine (1.0k citations). Henry Botto has collaborated with scholars based in France, Germany and Italy. Frequent co-authors include Thierry Lebrét, Kurt G. Naber, Vincent Molinié, Truls E. Bjerklund Johansen, Juan Palou, Teresita Mazzei, Pierre‐Marie Lugagne, François Richard, Jean-Marie Hervé and Péter Tenke. Their work appears in journals such as The Journal of Urology, European Urology, British Journal of Urology, World Journal of Urology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.